Search

WASHINGTON, DC — The U.S. Food and Drug Administration, in collaboration with major implantable pacemaker and ICD manufacturers, demonstrated the effects of emissions from radio frequency identification (RFID) readers on common implantable cardiac devices. According to research published in the January edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, the observed effects may cause increasing complications as RFID use expands in the medical device field.

WASHINGTON, DC — March 1, 2010 – Analysis of ICD patients enrolled in four different trials found patients with life-threatening ventricular arrhythmias (VA) treated only with antitachycardia pacing (ATP) have higher survival rates than VA patients who experienced at least one shock-treated episode. According to research published in the March edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, 80.2% of VA episodes were successfully treated with ATP-only therapy from an ICD.

WASHINGTON, July 1, 2010 — New large meta-analysis from five primary prevention randomized implantable cardioverter-defibrillator (ICD) studies shows a smaller impact of Sudden Cardiac Death (SCD) on overall mortality in women.  According to research published in the July edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, women in primary prevention ICD trials have the same overall mortality as men, while experiencing significantly less appropriate ICD interventions. With more than 1,600 women, this meta-analysis includes the largest cohort of women to date.  

Lack of awareness and treatment of sudden cardiac arrest (SCA) puts African Americans at greater risk of death from the condition, according to a new national survey released today by the Heart Rhythm Society (HRS). The survey findings uncovered significant perception gaps between healthcare providers and consumers when it comes to understanding the condition, its symptoms, risk factors and treatments. Responsible for more than 350,000 U.S. deaths each year, SCA occurs when the heart suddenly and unexpectedly stops beating. Approximately 95 percent of SCA cases result in death; however, it is proven most deadly in African Americans.